nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezetimibe—Pain in arm—Hydrochlorothiazide—nephrolithiasis	0.0632	0.136	CcSEcCtD
Ezetimibe—UGT1A1—urine—nephrolithiasis	0.0321	0.15	CbGeAlD
Ezetimibe—Creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.0197	0.0426	CcSEcCtD
Ezetimibe—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.0151	0.0325	CcSEcCtD
Ezetimibe—SOAT1—nephron tubule—nephrolithiasis	0.0143	0.0668	CbGeAlD
Ezetimibe—ANPEP—nephron tubule—nephrolithiasis	0.0137	0.0639	CbGeAlD
Ezetimibe—Memory impairment—Hydrochlorothiazide—nephrolithiasis	0.0132	0.0285	CcSEcCtD
Ezetimibe—SOAT1—renal system—nephrolithiasis	0.013	0.0607	CbGeAlD
Ezetimibe—Gamma-glutamyltransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0126	0.0272	CcSEcCtD
Ezetimibe—ANPEP—renal system—nephrolithiasis	0.0124	0.0581	CbGeAlD
Ezetimibe—ANPEP—kidney—nephrolithiasis	0.012	0.0562	CbGeAlD
Ezetimibe—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.0117	0.0253	CcSEcCtD
Ezetimibe—ANPEP—cortex of kidney—nephrolithiasis	0.0117	0.0547	CbGeAlD
Ezetimibe—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0248	CcSEcCtD
Ezetimibe—UGT2B15—Phase II conjugation—SLC26A1—nephrolithiasis	0.0113	0.035	CbGpPWpGaD
Ezetimibe—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0229	CcSEcCtD
Ezetimibe—CYP3A4—urine—nephrolithiasis	0.0103	0.048	CbGeAlD
Ezetimibe—UGT2B7—renal system—nephrolithiasis	0.00923	0.0431	CbGeAlD
Ezetimibe—UGT2B7—kidney—nephrolithiasis	0.00893	0.0417	CbGeAlD
Ezetimibe—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.00857	0.0185	CcSEcCtD
Ezetimibe—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.00805	0.0174	CcSEcCtD
Ezetimibe—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.00798	0.0172	CcSEcCtD
Ezetimibe—UGT1A1—renal system—nephrolithiasis	0.00785	0.0367	CbGeAlD
Ezetimibe—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00774	0.0167	CcSEcCtD
Ezetimibe—UGT1A1—kidney—nephrolithiasis	0.00759	0.0355	CbGeAlD
Ezetimibe—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00753	0.0162	CcSEcCtD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00745	0.0231	CbGpPWpGaD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00745	0.0231	CbGpPWpGaD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00717	0.0222	CbGpPWpGaD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00717	0.0222	CbGpPWpGaD
Ezetimibe—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.00695	0.015	CcSEcCtD
Ezetimibe—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.0068	0.0147	CcSEcCtD
Ezetimibe—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00678	0.0146	CcSEcCtD
Ezetimibe—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00678	0.0146	CcSEcCtD
Ezetimibe—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00666	0.0144	CcSEcCtD
Ezetimibe—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00664	0.0143	CcSEcCtD
Ezetimibe—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00664	0.0143	CcSEcCtD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00664	0.0206	CbGpPWpGaD
Ezetimibe—UGT2B15—Biological oxidations—SLC26A1—nephrolithiasis	0.0066	0.0205	CbGpPWpGaD
Ezetimibe—SLCO1B1—renal system—nephrolithiasis	0.00653	0.0305	CbGeAlD
Ezetimibe—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00651	0.014	CcSEcCtD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00639	0.0198	CbGpPWpGaD
Ezetimibe—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00638	0.0138	CcSEcCtD
Ezetimibe—SLCO1B1—kidney—nephrolithiasis	0.00632	0.0295	CbGeAlD
Ezetimibe—ABCC3—renal system—nephrolithiasis	0.0062	0.029	CbGeAlD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00607	0.0188	CbGpPWpGaD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00607	0.0188	CbGpPWpGaD
Ezetimibe—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00605	0.013	CcSEcCtD
Ezetimibe—UGT1A3—Phase II conjugation—SLC26A1—nephrolithiasis	0.00604	0.0187	CbGpPWpGaD
Ezetimibe—ABCC3—kidney—nephrolithiasis	0.00599	0.028	CbGeAlD
Ezetimibe—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00599	0.0129	CcSEcCtD
Ezetimibe—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00594	0.0128	CcSEcCtD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00584	0.0181	CbGpPWpGaD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00584	0.0181	CbGpPWpGaD
Ezetimibe—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00569	0.0123	CcSEcCtD
Ezetimibe—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00565	0.0122	CcSEcCtD
Ezetimibe—ABCG2—Iron uptake and transport—ATP6V0A4—nephrolithiasis	0.0056	0.0174	CbGpPWpGaD
Ezetimibe—ABCC2—nephron tubule—nephrolithiasis	0.00545	0.0254	CbGeAlD
Ezetimibe—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00544	0.0117	CcSEcCtD
Ezetimibe—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00521	0.0112	CcSEcCtD
Ezetimibe—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00517	0.0112	CcSEcCtD
Ezetimibe—UGT2B7—Phase II conjugation—SLC26A1—nephrolithiasis	0.00514	0.0159	CbGpPWpGaD
Ezetimibe—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00513	0.0111	CcSEcCtD
Ezetimibe—ABCC2—renal system—nephrolithiasis	0.00495	0.0231	CbGeAlD
Ezetimibe—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00492	0.0106	CcSEcCtD
Ezetimibe—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00483	0.0104	CcSEcCtD
Ezetimibe—ABCC2—kidney—nephrolithiasis	0.00479	0.0224	CbGeAlD
Ezetimibe—ABCC2—cortex of kidney—nephrolithiasis	0.00466	0.0218	CbGeAlD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.0046	0.0143	CbGpPWpGaD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.0046	0.0143	CbGpPWpGaD
Ezetimibe—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.0046	0.00993	CcSEcCtD
Ezetimibe—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00453	0.00978	CcSEcCtD
Ezetimibe—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00447	0.00964	CcSEcCtD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00443	0.0137	CbGpPWpGaD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00443	0.0137	CbGpPWpGaD
Ezetimibe—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00438	0.00946	CcSEcCtD
Ezetimibe—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00436	0.0094	CcSEcCtD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00428	0.0133	CbGpPWpGaD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00428	0.0133	CbGpPWpGaD
Ezetimibe—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00421	0.00908	CcSEcCtD
Ezetimibe—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00419	0.00904	CcSEcCtD
Ezetimibe—UGT1A1—Phase II conjugation—SLC26A1—nephrolithiasis	0.00417	0.0129	CbGpPWpGaD
Ezetimibe—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00414	0.00894	CcSEcCtD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00412	0.0128	CbGpPWpGaD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00412	0.0128	CbGpPWpGaD
Ezetimibe—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00409	0.00882	CcSEcCtD
Ezetimibe—UGT1A3—NRF2 pathway—SLC2A9—nephrolithiasis	0.00403	0.0125	CbGpPWpGaD
Ezetimibe—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00401	0.00864	CcSEcCtD
Ezetimibe—ABCG2—nephron tubule—nephrolithiasis	0.00397	0.0186	CbGeAlD
Ezetimibe—Cough—Hydrochlorothiazide—nephrolithiasis	0.00396	0.00854	CcSEcCtD
Ezetimibe—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00386	0.00833	CcSEcCtD
Ezetimibe—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00386	0.00833	CcSEcCtD
Ezetimibe—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00386	0.00833	CcSEcCtD
Ezetimibe—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00381	0.00823	CcSEcCtD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00381	0.0118	CbGpPWpGaD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00381	0.0118	CbGpPWpGaD
Ezetimibe—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00377	0.00814	CcSEcCtD
Ezetimibe—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00373	0.00805	CcSEcCtD
Ezetimibe—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.0037	0.00798	CcSEcCtD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00367	0.0114	CbGpPWpGaD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00367	0.0114	CbGpPWpGaD
Ezetimibe—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00362	0.00782	CcSEcCtD
Ezetimibe—UGT1A3—Biological oxidations—SLC26A1—nephrolithiasis	0.00353	0.011	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—GRHPR—nephrolithiasis	0.00349	0.0108	CbGpPWpGaD
Ezetimibe—ABCC3—NRF2 pathway—SLC2A9—nephrolithiasis	0.00343	0.0106	CbGpPWpGaD
Ezetimibe—UGT2B7—NRF2 pathway—SLC2A9—nephrolithiasis	0.00343	0.0106	CbGpPWpGaD
Ezetimibe—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00337	0.00727	CcSEcCtD
Ezetimibe—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00335	0.00722	CcSEcCtD
Ezetimibe—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00332	0.00717	CcSEcCtD
Ezetimibe—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.0033	0.00712	CcSEcCtD
Ezetimibe—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00326	0.00703	CcSEcCtD
Ezetimibe—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00322	0.00694	CcSEcCtD
Ezetimibe—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00319	0.00688	CcSEcCtD
Ezetimibe—Pain—Hydrochlorothiazide—nephrolithiasis	0.00316	0.00683	CcSEcCtD
Ezetimibe—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00316	0.00683	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism—AGXT—nephrolithiasis	0.00311	0.00964	CbGpPWpGaD
Ezetimibe—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00305	0.00658	CcSEcCtD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00305	0.00945	CbGpPWpGaD
Ezetimibe—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00302	0.00653	CcSEcCtD
Ezetimibe—UGT2B7—Biological oxidations—SLC26A1—nephrolithiasis	0.00301	0.00932	CbGpPWpGaD
Ezetimibe—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00294	0.00634	CcSEcCtD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00293	0.0091	CbGpPWpGaD
Ezetimibe—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00292	0.00631	CcSEcCtD
Ezetimibe—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00292	0.00631	CcSEcCtD
Ezetimibe—UGT1A1—NRF2 pathway—SLC2A9—nephrolithiasis	0.00278	0.00863	CbGpPWpGaD
Ezetimibe—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00273	0.00588	CcSEcCtD
Ezetimibe—ABCC2—NRF2 pathway—SLC2A9—nephrolithiasis	0.00272	0.00842	CbGpPWpGaD
Ezetimibe—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00265	0.00573	CcSEcCtD
Ezetimibe—ABCG8—Metabolism—GRHPR—nephrolithiasis	0.00264	0.0082	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—APRT—nephrolithiasis	0.00264	0.0082	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—SLC26A1—nephrolithiasis	0.00264	0.0082	CbGpPWpGaD
Ezetimibe—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00262	0.00565	CcSEcCtD
Ezetimibe—ABCG5—Metabolism—GRHPR—nephrolithiasis	0.00254	0.00789	CbGpPWpGaD
Ezetimibe—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00253	0.00546	CcSEcCtD
Ezetimibe—CYP3A4—renal system—nephrolithiasis	0.00252	0.0118	CbGeAlD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.0025	0.00774	CbGpPWpGaD
Ezetimibe—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00245	0.00528	CcSEcCtD
Ezetimibe—UGT1A1—Biological oxidations—SLC26A1—nephrolithiasis	0.00244	0.00757	CbGpPWpGaD
Ezetimibe—CYP3A4—kidney—nephrolithiasis	0.00243	0.0114	CbGeAlD
Ezetimibe—ABCG8—Metabolism—AGXT—nephrolithiasis	0.00236	0.00731	CbGpPWpGaD
Ezetimibe—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00235	0.00508	CcSEcCtD
Ezetimibe—Rash—Hydrochlorothiazide—nephrolithiasis	0.00233	0.00503	CcSEcCtD
Ezetimibe—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00233	0.00503	CcSEcCtD
Ezetimibe—Headache—Hydrochlorothiazide—nephrolithiasis	0.00232	0.005	CcSEcCtD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00228	0.00708	CbGpPWpGaD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00228	0.00708	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—AGXT—nephrolithiasis	0.00227	0.00703	CbGpPWpGaD
Ezetimibe—Nausea—Hydrochlorothiazide—nephrolithiasis	0.0022	0.00474	CcSEcCtD
Ezetimibe—ABCG8—Metabolism—SLC26A1—nephrolithiasis	0.002	0.00621	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—APRT—nephrolithiasis	0.002	0.00621	CbGpPWpGaD
Ezetimibe—ABCB1—nephron tubule—nephrolithiasis	0.00196	0.00915	CbGeAlD
Ezetimibe—ABCG5—Metabolism—SLC26A1—nephrolithiasis	0.00193	0.00598	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—APRT—nephrolithiasis	0.00193	0.00598	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00191	0.00592	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00191	0.00592	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—AQP1—nephrolithiasis	0.00188	0.00584	CbGpPWpGaD
Ezetimibe—ABCB1—renal system—nephrolithiasis	0.00178	0.00832	CbGeAlD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00173	0.00536	CbGpPWpGaD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00173	0.00536	CbGpPWpGaD
Ezetimibe—ABCB1—kidney—nephrolithiasis	0.00172	0.00804	CbGeAlD
Ezetimibe—NPC1L1—Metabolism—CHRM3—nephrolithiasis	0.0017	0.00528	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.0017	0.00528	CbGpPWpGaD
Ezetimibe—ABCB1—cortex of kidney—nephrolithiasis	0.00168	0.00783	CbGeAlD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00161	0.00499	CbGpPWpGaD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00161	0.00499	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00156	0.00483	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00156	0.00483	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00151	0.0047	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00151	0.0047	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—GRHPR—nephrolithiasis	0.00149	0.00462	CbGpPWpGaD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00143	0.00444	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—AQP1—nephrolithiasis	0.00143	0.00443	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00142	0.00441	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00142	0.00441	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—AQP1—nephrolithiasis	0.00137	0.00426	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00135	0.00419	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—AGXT—nephrolithiasis	0.00133	0.00412	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00132	0.00408	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00132	0.00408	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—CHRM3—nephrolithiasis	0.00129	0.004	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00127	0.00393	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—CHRM3—nephrolithiasis	0.00124	0.00385	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00123	0.00383	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00123	0.00383	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00118	0.00366	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00118	0.00366	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00117	0.00364	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00116	0.0036	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00116	0.0036	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—SLC26A1—nephrolithiasis	0.00113	0.0035	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—APRT—nephrolithiasis	0.00113	0.0035	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.0011	0.0034	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.0011	0.0034	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00107	0.00333	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00107	0.00333	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000978	0.00303	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000978	0.00303	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000936	0.0029	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000936	0.0029	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000879	0.00273	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000879	0.00273	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00087	0.0027	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00087	0.0027	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000817	0.00253	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000817	0.00253	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000814	0.00252	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000814	0.00252	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—AQP1—nephrolithiasis	0.000804	0.00249	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GRHPR—nephrolithiasis	0.000798	0.00247	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000782	0.00242	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000775	0.0024	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000775	0.0024	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000757	0.00235	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000757	0.00235	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000728	0.00226	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000728	0.00226	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—CHRM3—nephrolithiasis	0.000727	0.00225	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000712	0.00221	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000712	0.00221	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—AGXT—nephrolithiasis	0.000711	0.0022	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.00069	0.00214	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GRHPR—nephrolithiasis	0.000678	0.0021	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GRHPR—nephrolithiasis	0.000678	0.0021	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000674	0.00209	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000674	0.00209	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000635	0.00197	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00062	0.00192	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—SLC26A1—nephrolithiasis	0.000604	0.00187	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—AGXT—nephrolithiasis	0.000604	0.00187	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—APRT—nephrolithiasis	0.000604	0.00187	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—AGXT—nephrolithiasis	0.000604	0.00187	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000582	0.00181	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000581	0.0018	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000581	0.0018	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GRHPR—nephrolithiasis	0.000551	0.00171	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000539	0.00167	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—SLC26A1—nephrolithiasis	0.000514	0.00159	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—APRT—nephrolithiasis	0.000514	0.00159	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—APRT—nephrolithiasis	0.000514	0.00159	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—SLC26A1—nephrolithiasis	0.000514	0.00159	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GRHPR—nephrolithiasis	0.000505	0.00157	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—AGXT—nephrolithiasis	0.000491	0.00152	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GRHPR—nephrolithiasis	0.000468	0.00145	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—AGXT—nephrolithiasis	0.00045	0.0014	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00044	0.00136	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00044	0.00136	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—AQP1—nephrolithiasis	0.000431	0.00134	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—SLC26A1—nephrolithiasis	0.000418	0.0013	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—APRT—nephrolithiasis	0.000418	0.0013	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—AGXT—nephrolithiasis	0.000417	0.00129	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000409	0.00127	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000409	0.00127	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CHRM3—nephrolithiasis	0.00039	0.00121	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—APRT—nephrolithiasis	0.000383	0.00119	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—SLC26A1—nephrolithiasis	0.000383	0.00119	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—AQP1—nephrolithiasis	0.000366	0.00114	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—AQP1—nephrolithiasis	0.000366	0.00114	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000365	0.00113	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000365	0.00113	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—APRT—nephrolithiasis	0.000354	0.0011	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—SLC26A1—nephrolithiasis	0.000354	0.0011	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CHRM3—nephrolithiasis	0.000331	0.00103	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CHRM3—nephrolithiasis	0.000331	0.00103	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—AQP1—nephrolithiasis	0.000298	0.000923	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000291	0.000904	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—AQP1—nephrolithiasis	0.000273	0.000846	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CHRM3—nephrolithiasis	0.000269	0.000835	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.000253	0.000784	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—AQP1—nephrolithiasis	0.000253	0.000783	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CHRM3—nephrolithiasis	0.000247	0.000765	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CHRM3—nephrolithiasis	0.000228	0.000708	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—AGXT—nephrolithiasis	0.000225	0.000699	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.000192	0.000594	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—APRT—nephrolithiasis	0.000192	0.000594	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000156	0.000483	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000139	0.00043	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—AQP1—nephrolithiasis	0.000137	0.000423	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CHRM3—nephrolithiasis	0.000123	0.000383	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000118	0.000366	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000118	0.000366	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—AQP1—nephrolithiasis	8.41e-05	0.000261	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CHRM3—nephrolithiasis	7.61e-05	0.000236	CbGpPWpGaD
